• 177Lu DOTATATE (I+D)

    177Lu DOTATATE (I+D)
    It is a radiolabeled somatostatin analog indicated for: - The treatment of gastroenteropancreatic tumors positive for the somatostatin receptor. Neuroendocrine tumors (GEP-NETs), including the foregut...
  • 177Lu PSMA (R+D)

    177Lu PSMA (R+D)
    Radiopharmaceutical used in the treatment of advanced metastatic castration-resistant prostate cancer that presents positive prostate-specific membrane antigen and has not responded effectively to treatment with other...
  • CAPSUBAC

    CAPSUBAC
    It is indicated for the treatment of hyperthyroidism and in special cases of thyroid carcinoma. This medicine is for therapeutic use in: - Graves' disease, single or multiple diffuse toxic multinodular...
  • MIBG 131 WITHOUT CARRIER (R&D)

    MIBG 131 WITHOUT CARRIER (R&D)
    It is a radioactive therapeutic agent indicated for ...
  • TERABAC

    TERABAC
    It is indicated for the treatment of hyperthyroidism (diffuse toxic goiter or nodular multiple toxic goiter). Diagnosis: - For the pre-therapeutic determination of the kinetics of radioactive iodine (determination...

Title

Go to Top